Logiscreen

Penumbra Inc

$320.53
Market Cap 12.58B
ROE 12.3%
Gross Margin 67.6%
Debt/Equity 0.1
Current Ratio 6.0
Revenue QoQ 15.6%
EPS QoQ -0.2%
F-Score 4

About

Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT™), centers on removing blood clots from head-to-toe with speed, safety, and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
73.56
vs median 33.61
P/B
8.54
vs median 2.16
ROE
0.12
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics